Sanofi Pulls Obesity Drug Acomplia From EU Market

Law360, New York (October 23, 2008, 12:00 AM EDT) -- French drugmaker Sanofi-Aventis has agreed to stop selling the anti-obesity drug Acomplia after European authorities called for sales of the drug to be suspended.

The European Medicines Agency issued a notice on Thursday asking Sanofi to stop marketing Acomplia, alleging that the risks of the drug outweigh its benefits.

The agency, responsible for evaluating products in the European Union, said that the diet drug carried an approximately doubled risk of psychiatric disorders compared with a placebo.

The results of the study will be sent to the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.